About this Journal Submit a Manuscript Table of Contents
Anatomy Research International
Volume 2012 (2012), Article ID 953264, 15 pages
http://dx.doi.org/10.1155/2012/953264
Review Article

Erythropoietin in Brain Development and Beyond

Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1822, USA

Received 13 June 2011; Revised 27 October 2011; Accepted 11 November 2011

Academic Editor: Daniele Bani

Copyright © 2012 Mawadda Alnaeeli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F.-K. Lin, S. Suggs, and C.-H. Lin, “Cloning and expression of the human erythropoietin gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 22, pp. 7580–7584, 1985.
  2. K. Jacobs, C. Shoemaker, and R. Rudersdorf, “Isolation and characterization of genomic and cDNA clones of human erythropoietin,” Nature, vol. 313, no. 6005, pp. 806–810, 1985.
  3. P.-H. Lai, R. Everett, and F.-F. Wang, “Structural characterization of human erythropoietin,” Journal of Biological Chemistry, vol. 261, no. 7, pp. 3116–3121, 1986. View at Scopus
  4. H. Sasaki, B. Bothner, A. Dell, and M. Fukuda, “Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA,” Journal of Biological Chemistry, vol. 262, no. 25, pp. 12059–12076, 1987. View at Scopus
  5. M. N. Fukuda, H. Sasaki, L. Lopez, and M. Fukuda, “Survival of recombinant erythropoietin in the circulation: the role of carbohydrates,” Blood, vol. 73, no. 1, pp. 84–89, 1989. View at Scopus
  6. A. D. D'Andrea and Y. Zhu, “Cloning and functional analysis of erythropoietin-, interleukin-3-and thrombopoietin-inducible genes,” Stem Cells, vol. 14, no. 1, pp. 82–87, 1996. View at Scopus
  7. D. Wen, J. P. Boissel, M. Showers, B. C. Ruch, and H. F. Bunn, “Erythropoietin structure-function relationships. Identification of functionally important domains,” Journal of Biological Chemistry, vol. 269, no. 36, pp. 22839–22846, 1994. View at Scopus
  8. E. Parganas, D. Wang, D. Stravopodis et al., “Jak2 is essential for signaling through a variety of cytokine receptors,” Cell, vol. 93, no. 3, pp. 385–395, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Syed, S. W. Reid, C. Li et al., “Efficiency of signalling through cytokine receptors depends critically on receptor orientation,” Nature, vol. 395, no. 6701, pp. 511–516, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. T. Noguchi, K. S. Bae, K. Chin, Y. Wada, A. N. Schechter, and W. D. Hankins, “Cloning of the human erythropoietin receptor gene,” Blood, vol. 78, no. 10, pp. 2548–2556, 1991. View at Scopus
  11. H. Youssoufian, G. Longmore, D. Neumann, A. Yoshimura, and H. F. Lodish, “Structure, function, and activation of the erythropoietin receptor,” Blood, vol. 81, no. 9, pp. 2223–2236, 1993. View at Scopus
  12. M. Funakoshi-Tago, S. Pelletier, H. Moritake, E. Parganas, and J. N. Ihle, “Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity,” Molecular and Cellular Biology, vol. 28, no. 5, pp. 1792–1801, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. O. Livnah, E. A. Stura, S. A. Middleton, D. L. Johnson, L. K. Jolliffe, and I. A. Wilson, “Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation,” Science, vol. 283, no. 5404, pp. 987–990, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Wu, X. Liu, R. Jaenisch, and H. F. Lodish, “Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor,” Cell, vol. 83, no. 1, pp. 59–67, 1995. View at Scopus
  15. C. S. Lin, S. K. Lim, V. D'Agati, and F. Costantini, “Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erytnropoiesis,” Genes and Development, vol. 10, no. 2, pp. 154–164, 1996. View at Scopus
  16. J. Palis, K. E. McGrath, and P. D. Kingsley, “Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants,” Blood, vol. 86, no. 1, pp. 156–163, 1995. View at Scopus
  17. M. Peeters, K. Ottersbach, K. Bollerot et al., “Ventral embryonic tissues and Hedgehog proteins induce early AGM hematopoietic stem cell development,” Development, vol. 136, no. 15, pp. 2613–2621, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. R. Lee, N. Kertesz, S. B. Joseph, A. Jegalian, and H. Wu, “Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis,” Blood, vol. 98, no. 5, pp. 1408–1415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. K. McGann, L. Silver, J. Liesveld, and J. Palis, “Erythropoietin-receptor expression and function during the initiation of murine yolk sac erythropoiesis,” Experimental Hematology, vol. 25, no. 11, pp. 1149–1157, 1997. View at Scopus
  20. F. Zimmermann and I. N. Rich, “Mammalian homeobox B6 expression can be correlated with erythropoietin production sites and erythropoiesis during development, but not with hematopoietic or nonhematopoietic stem cell populations,” Blood, vol. 89, no. 8, pp. 2723–2735, 1997. View at Scopus
  21. N. Obara, N. Suzuki, K. Kim, T. Nagasawa, S. Imagawa, and M. Yamamoto, “Repression via the GATA box is essential for tissue-specific erythropoietin gene expression,” Blood, vol. 111, no. 10, pp. 5223–5232, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. G. L. Semenza, S. T. Koury, M. K. Nejfelt, J. D. Gearhart, and S. E. Antonarakis, “Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 19, pp. 8725–8729, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. S. T. Koury, M. C. Bondurant, and M. J. Koury, “Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization,” Blood, vol. 71, no. 2, pp. 524–527, 1988. View at Scopus
  24. P. H. Maxwell, M. K. Osmond, C. W. Pugh et al., “Identification of the renal erythropoietin-producing cells using transgenic mice,” Kidney International, vol. 44, no. 5, pp. 1149–1162, 1993. View at Scopus
  25. C. C. Tan, K. Eckardt, and P. J. Ratcliffe, “Organ distribution of erythropoietin messenger RNA in normal and uremic rats,” Kidney International, vol. 40, no. 1, pp. 69–76, 1991. View at Scopus
  26. J. Fandrey and H. F. Bunn, “In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction,” Blood, vol. 81, no. 3, pp. 617–623, 1993. View at Scopus
  27. J. Köchling, P. T. Curtin, and A. Madan, “Regulation of human erythropoietin gene induction by upstream flanking sequences in transgenic mice,” British Journal of Haematology, vol. 103, no. 4, pp. 960–968, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. S. T. Koury, M. C. Bondurant, M. J. Koury, and G. L. Semenza, “Localization of cells producing erythropoietin in murine liver by in situ hybridization,” Blood, vol. 77, no. 11, pp. 2497–2503, 1991. View at Scopus
  29. Y. Yasuda, S. Masuda, M. Chikuma, K. Inoue, M. Nagao, and R. Sasaki, “Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis,” Journal of Biological Chemistry, vol. 273, no. 39, pp. 25381–25387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Chikuma, S. Masuda, T. Kobayashi, M. Nagao, and R. Sasaki, “Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus,” American Journal of Physiology, vol. 279, no. 6, pp. E1242–E1248, 2000.
  31. M. Magnanti, O. Gandini, L. Giuliani et al., “Erythropoietin expression in primary rat Sertoli and peritubular myoid cells,” Blood, vol. 98, no. 9, pp. 2872–2874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Kobayashi, H. Yanase, T. Iwanaga, R. Sasaki, and M. Nagao, “Epididymis is a novel site of erythropoietin production in mouse reproductive organs,” Biochemical and Biophysical Research Communications, vol. 296, no. 1, pp. 145–151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. H. H. Marti, “Erythropoietin gene expression in human, monkey and murine brain,” European Journal of Neuroscience, vol. 8, no. 4, pp. 666–676, 1996. View at Publisher · View at Google Scholar
  34. S. Masuda, M. Okano, K. Yamagishi, M. Nagao, M. Ueda, and R. Sasaki, “A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes,” Journal of Biological Chemistry, vol. 269, no. 30, pp. 19488–19493, 1994. View at Scopus
  35. C. Dame, P. Bartmann, E. M. Wolber, H. Fahnenstich, D. Hofmann, and J. Fandrey, “Erythropoietin gene expression in different areas of the developing human central nervous system,” Developmental Brain Research, vol. 125, no. 1-2, pp. 69–74, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. S. E. Juul, A. T. Yachnis, A. M. Rojiani, and R. D. Christensen, “Immunohistochemical localization of erythropoietin and its receptor in the developing human brain,” Pediatric and Developmental Pathology, vol. 2, no. 2, pp. 148–158, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Li, S. E. Juul, J. A. Morris-Wiman, D. A. Calhoun, and R. D. Christensen, “Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses,” Pediatric Research, vol. 40, no. 3, pp. 376–380, 1996. View at Scopus
  38. S. E. Juul, D. K. Anderson, Y. Li, and R. D. Christensen, “Erythropoietin and erythropoietin receptor in the developing human central nervous system,” Pediatric Research, vol. 43, no. 1, pp. 40–49, 1998. View at Scopus
  39. C. Grimm, A. Wenzel, M. Groszer et al., “HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration,” Nature Medicine, vol. 8, no. 7, pp. 718–724, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. E. Juul, A. T. Yachnis, and R. D. Christensen, “Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus,” Early Human Development, vol. 52, no. 3, pp. 235–249, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. S. E. Juul, J. Harcum, Y. Li, and R. D. Christensen, “Erythropoietin is present in the cerebrospinal fluid of neonates,” Journal of Pediatrics, vol. 130, no. 3, pp. 428–430, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Beck, S. Ramirez, R. Weinmann, and J. Caro, “Enhancer element at the 3'-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene,” Journal of Biological Chemistry, vol. 266, no. 24, pp. 15563–15566, 1991. View at Scopus
  43. G. L. Semenza, M. K. Nejfelt, S. M. Chi, and S. E. Antonarakis, “Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 13, pp. 5680–5684, 1991. View at Publisher · View at Google Scholar · View at Scopus
  44. K. L. Blanchard, A. M. Acquaviva, D. L. Galson, and H. F. Bunn, “Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements,” Molecular and Cellular Biology, vol. 12, no. 12, pp. 5373–5385, 1992. View at Scopus
  45. H. F. Bunn, J. Gu, L. E. Huang, J. W. Park, and H. Zhu, “Erythropoietin: a model system for studying oxygen-dependent gene regulation,” Journal of Experimental Biology, vol. 201, no. 8, pp. 1197–1201, 1998. View at Scopus
  46. T. G. Smith, P. A. Robbins, and P. J. Ratcliffe, “The human side of hypoxia-inducible factor,” British Journal of Haematology, vol. 141, no. 3, pp. 325–334, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. E. Metzen and P. J. Ratcliffe, “HIF hydroxylation and cellular oxygen sensing,” Biological Chemistry, vol. 385, no. 3-4, pp. 223–230, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. M. J. Percy, P. W. Furlow, G. S. Lucas et al., “A gain-of-function mutation in the HIF2A gene in familial erythrocytosis,” New England Journal of Medicine, vol. 358, no. 2, pp. 162–168, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. E. B. Rankin, M. P. Biju, Q. Liu et al., “Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo,” Journal of Clinical Investigation, vol. 117, no. 4, pp. 1068–1077, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. J. C. Chavez, O. Baranova, J. Lin, and P. Pichiule, “The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes,” Journal of Neuroscience, vol. 26, no. 37, pp. 9471–9481, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. C. Warnecke, Z. Zaborowska, J. Kurreck et al., “Differentiating the functional role of hypoxia-inducible factor (HIF)-1α and HIF-2α (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells,” FASEB Journal, vol. 18, no. 12, pp. 1462–1464, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. M. Morita, O. Ohneda, T. Yamashita et al., “HLF/HIF-2α is a key factor in retinopathy of prematurity in association with erythropoietin,” EMBO Journal, vol. 22, no. 5, pp. 1134–1146, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. M. Gruber, C. J. Hu, R. S. Johnson, E. J. Brown, B. Keith, and M. C. Simon, “Acute postnatal ablation of Hif-2α results in anemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 7, pp. 2301–2306, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. N. Tang, L. Wang, J. Esko et al., “Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis,” Cancer Cell, vol. 6, no. 5, pp. 485–495, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. G. L. Semenza, “Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis,” Blood, vol. 114, no. 10, pp. 2015–2019, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. S. Imagawa, M. Yamamoto, and Y. Miura, “Negative regulation of the erythropoietin gene expression by the GATA transcription factors,” Blood, vol. 89, no. 4, pp. 1430–1439, 1997. View at Scopus
  57. C. Dame, M. C. Sola, K. C. Lim et al., “Hepatic erythropoietin gene regulation by GATA-4,” Journal of Biological Chemistry, vol. 279, no. 4, pp. 2955–2961, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. C. Dame, K. M. Kirschner, K. V. Bartz, T. Wallach, C. S. Hussels, and H. Scholz, “Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene,” Blood, vol. 107, no. 11, pp. 4282–4290, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. A. Anagnostou, E. S. Lee, N. Kessimian, R. Levinson, and M. Steiner, “Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 15, pp. 5978–5982, 1990. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Anagnostou, Z. Liu, M. Steiner et al., “Erythropoietin receptor mRNA expression in human endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 9, pp. 3974–3978, 1994. View at Scopus
  61. N. Kertesz, J. Wu, T. H. P. Chen, H. M. Sucov, and H. Wu, “The role of erythropoietin in regulating angiogenesis,” Developmental Biology, vol. 276, no. 1, pp. 101–110, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. B. B. Beleslin-Cokic, V. P. Cokic, X. Yu, B. B. Weksler, A. N. Schechter, and C. T. Noguchi, “Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells,” Blood, vol. 104, no. 7, pp. 2073–2080, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. B. B. Beleslin-Čokić, V. P. Čokić, L. Wang et al., “Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells,” Cytokine, vol. 54, no. 2, pp. 129–135, 2011. View at Publisher · View at Google Scholar · View at PubMed
  64. B. D. Westenbrink, E. Lipšic, P. Van Der Meer et al., “Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization,” European Heart Journal, vol. 28, no. 16, pp. 2018–2027, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. R. Teng, J. W. Calvert, N. Sibmooh et al., “Acute erythropoietin cardioprotection is mediated by endothelial response,” Basic Research in Cardiology, vol. 106, no. 3, pp. 343–354, 2011. View at Publisher · View at Google Scholar · View at PubMed
  66. N. Urao, M. Okigaki, H. Yamada et al., “Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia,” Circulation Research, vol. 98, no. 11, pp. 1405–1413, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. R. Zhande and A. Karsan, “Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-κB-independent upregulation of Bcl-xL,” American Journal of Physiology, vol. 292, no. 5, pp. H2467–H2474, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. Z. Y. Liu, K. Chin, and C. T. Noguchi, “Tissue specific expression of human erythropoietin receptor in transgenic mice,” Developmental Biology, vol. 166, no. 1, pp. 159–169, 1994. View at Publisher · View at Google Scholar · View at PubMed
  69. X. Yu, J. J. Shacka, J. B. Eells et al., “Erythropoietin receptor signalling is required for normal brain development,” Development, vol. 129, no. 2, pp. 505–516, 2002.
  70. S. Masuda, M. Nagao, K. Takahata et al., “Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells,” Journal of Biological Chemistry, vol. 268, no. 15, pp. 11208–11216, 1993.
  71. P. E. Sanchez, R. P. Fares, J. J. Risso et al., “Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 24, pp. 9848–9853, 2009. View at Publisher · View at Google Scholar · View at PubMed
  72. C. Liu, K. Shen, Z. Liu, and C. T. Noguchi, “Regulated human erythropoietin receptor expression in mouse brain,” Journal of Biological Chemistry, vol. 272, no. 51, pp. 32395–32400, 1997. View at Publisher · View at Google Scholar
  73. K. Chin, N. Oda, K. Shen, and C. T. Noguchi, “Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs,” Nucleic Acids Research, vol. 23, no. 15, pp. 3041–3049, 1995.
  74. W. Knabe, F. Knerlich, S. Washausen et al., “Expression patterns of erythropoietin and its receptor in the developing midbrain,” Anatomy and Embryology, vol. 207, no. 6, pp. 503–512, 2004. View at Publisher · View at Google Scholar · View at PubMed
  75. W. Knabe, A. L. Sirén, H. Ehrenreich, and H. J. Kuhn, “Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia,” Anatomy and Embryology, vol. 210, no. 3, pp. 209–219, 2005. View at Publisher · View at Google Scholar · View at PubMed
  76. M. Brines, G. Grasso, F. Fiordaliso et al., “Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 41, pp. 14907–14912, 2004. View at Publisher · View at Google Scholar · View at PubMed
  77. M. Um, A. W. Gross, and H. F. Lodish, “A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells,” Cellular Signalling, vol. 19, no. 3, pp. 634–645, 2007. View at Publisher · View at Google Scholar · View at PubMed
  78. P. E. Sanchez, F. P. Navarro, R. P. Fares et al., “Erythropoietin receptor expression is concordant with erythropoietin but not with common β chain expression in the rat brain throughout the life span,” Journal of Comparative Neurology, vol. 514, no. 4, pp. 403–414, 2009. View at Publisher · View at Google Scholar · View at PubMed
  79. M. Digicaylioglu, S. Bichet, H. H. Marti et al., “Localization of specific erythropoietin binding sites in defined areas of the mouse brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 9, pp. 3717–3720, 1995.
  80. T. Shingo, S. Todd Sorokan, T. Shimazaki, and S. Weiss, “Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells,” Journal of Neuroscience, vol. 21, no. 24, pp. 9733–9743, 2001.
  81. L. Studer, M. Csete, S. H. Lee et al., “Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen,” Journal of Neuroscience, vol. 20, no. 19, pp. 7377–7383, 2000.
  82. E. Morishita, S. Masuda, M. Nagao, Y. Yasuda, and R. Sasaki, “Erythropoetin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death,” Neuroscience, vol. 76, no. 1, pp. 105–116, 1996. View at Publisher · View at Google Scholar
  83. Z. Y. Chen, P. Asavaritikrai, J. T. Prchal, and C. T. Noguchi, “Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation,” Journal of Biological Chemistry, vol. 282, no. 35, pp. 25875–25883, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. P. Lewczuk, M. Hasselblatt, H. Kamrowski-Kruck et al., “Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin,” NeuroReport, vol. 11, no. 16, pp. 3485–3488, 2000. View at Scopus
  85. K. Chin, X. Yu, B. Beleslin-Cokic et al., “Production and processing of erythropoietin receptor transcripts in brain,” Molecular Brain Research, vol. 81, no. 1-2, pp. 29–42, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. P. P. Pandolfi, M. E. Roth, A. Karis et al., “Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis,” Nature Genetics, vol. 11, no. 1, pp. 40–44, 1995. View at Scopus
  87. I. Wallach, J. Zhang, A. Hartmann et al., “Erythropoietin-receptor gene regulation in neuronal cells,” Pediatric Research, vol. 65, no. 6, pp. 619–624, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. C. L. Wu, S. D. Chen, J. H. Yin, C. S. Hwang, and D. I. Yang, “Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition,” Neurobiology of Disease, vol. 40, no. 1, pp. 146–154, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. L. Wang, Z. Zhang, Y. Wang, R. Zhang, and M. Chopp, “Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats,” Stroke, vol. 35, no. 7, pp. 1732–1737, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. Y. Wang, M. Yao, C. Zhou et al., “Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle,” Neuroscience, vol. 167, no. 3, pp. 750–757, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. X. Yu, C. S. Lin, F. Costantini, and C. T. Noguchi, “The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse,” Blood, vol. 98, no. 2, pp. 475–477, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. N. Suzuki, O. Ohneda, S. Takahashi et al., “Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality,” Blood, vol. 100, no. 7, pp. 2279–2288, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. P. T. Tsai, J. J. Ohab, N. Kertesz et al., “A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery,” Journal of Neuroscience, vol. 26, no. 4, pp. 1269–1274, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. K. Ruscher, D. Freyer, M. Karsch et al., “Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model,” Journal of Neuroscience, vol. 22, no. 23, pp. 10291–10301, 2002. View at Scopus
  95. E. Kilic, Ü. Kilic, J. Soliz, C. L. Bassetti, M. Gassmaim, and D. M. Hermann, “Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways,” FASEB Journal, vol. 19, no. 14, pp. 2026–2028, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. A. Sola, M. Rogido, B. H. Lee, T. Genetta, and T. C. Wen, “Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats,” Pediatric Research, vol. 57, no. 4, pp. 481–487, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. Z. Z. Chong, J. Q. Kang, and K. Maiese, “Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways,” British Journal of Pharmacology, vol. 138, no. 6, pp. 1107–1118, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. F. Zhang, A. P. Signore, Z. Zhou, S. Wang, G. Cao, and J. Chen, “Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms,” Journal of Neuroscience Research, vol. 83, no. 7, pp. 1241–1251, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. N. Byts, A. Samoylenko, T. Fasshauer et al., “Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin,” Cell Death and Differentiation, vol. 15, no. 4, pp. 783–792, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. M. Digicaylioglu and S. A. Lipton, “Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades,” Nature, vol. 412, no. 6847, pp. 641–647, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. R. Yamaji, T. Okada, M. Moriya et al., “Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA,” European Journal of Biochemistry, vol. 239, no. 2, pp. 494–500, 1996. View at Scopus
  102. M. Bernaudin, H. H. Marti, S. Roussel et al., “A potential role for erythropoietin in focal permanent cerebral ischemia in mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 6, pp. 643–651, 1999.
  103. Y. Li, Z. Lu, C. L. Keogh, S. P. Yu, and L. Wei, “Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 5, pp. 1043–1054, 2007. View at Publisher · View at Google Scholar · View at PubMed
  104. Z. Z. Chong, J. Q. Kang, and K. Maiese, “Erythropoietin is a novel vascular protectant through activation of AKt1 and mitochondrial modulation of cysteine proteases,” Circulation, vol. 106, no. 23, pp. 2973–2979, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. T. D. Palmer, A. R. Willhoite, and F. H. Gage, “Vascular niche for adult hippocampal neurogenesis,” Journal of Comparative Neurology, vol. 425, no. 4, pp. 479–494, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Jin, M. Minami, J. Q. Lan et al., “Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4710–4715, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, and O. Lindvall, “Neuronal replacement from endogenous precursors in the adult brain after stroke,” Nature Medicine, vol. 8, no. 9, pp. 963–970, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. A. Louissaint Jr., S. Rao, C. Leventhal, and S. A. Goldman, “Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain,” Neuron, vol. 34, no. 6, pp. 945–960, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. J. J. Ohab, S. Fleming, A. Blesch, and S. T. Carmichael, “A neurovascular niche for neurogenesis after stroke,” Journal of Neuroscience, vol. 26, no. 50, pp. 13007–13016, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. L. Wang, G. Z. Zheng, L. Z. Rui et al., “Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration,” Journal of Neuroscience, vol. 26, no. 22, pp. 5996–6003, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. H. Teng, Z. G. Zhang, L. Wang et al., “Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 4, pp. 764–771, 2008. View at Publisher · View at Google Scholar · View at PubMed
  112. L. Wang, M. Chopp, S. R. Gregg et al., “Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 7, pp. 1361–1368, 2008. View at Publisher · View at Google Scholar · View at PubMed
  113. H. Meng, Z. Zhang, R. Zhang et al., “Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors,” Neuroscience Letters, vol. 393, no. 2-3, pp. 97–101, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. F. M. Faraci, “Role of nitric oxide in regulation of basilar artery tone in vivo,” American Journal of Physiology, vol. 259, no. 4, pp. H1216–H1221, 1990. View at Scopus
  115. G. L. Baumbach, C. D. Sigmund, and F. M. Faraci, “Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase,” Circulation Research, vol. 95, no. 8, pp. 822–829, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. H. Kitaura, N. Uozumi, M. Tohmi et al., “Roles of nitric oxide as a vasodilator in neurovascular coupling of mouse somatosensory cortex,” Neuroscience Research, vol. 59, no. 2, pp. 160–171, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  117. B. Stefanovic, W. Schwindt, M. Hoehn, and A. C. Silva, “Functional uncoupling of hemodynamic from neuronal response by inhibition of neuronal nitric oxide synthase,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 4, pp. 741–754, 2007. View at Publisher · View at Google Scholar · View at PubMed
  118. S. Genc, F. Kuralay, K. Genc et al., “Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production,” Neuroscience Letters, vol. 298, no. 2, pp. 139–141, 2001. View at Publisher · View at Google Scholar · View at Scopus
  119. Z. Y. Chen, L. Wang, P. Asavaritkrai, and C. T. Noguchi, “Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning,” Journal of Neuroscience Research, vol. 88, no. 14, pp. 3180–3188, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. J. Tian, S. F. Kim, L. Hester, and S. H. Snyder, “S-nitrosylation/activation of COX-2 mediates NMDA neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10537–10540, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  121. S. F. Kim, D. A. Huri, and S. H. Snyder, “Medicine: inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2,” Science, vol. 310, no. 5756, pp. 1966–1970, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. C. Iadecola, F. Zhang, R. Casey, M. Nagayama, and M. Elizabeth Ross, “Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene,” Journal of Neuroscience, vol. 17, no. 23, pp. 9157–9164, 1997. View at Scopus
  123. Z. Huang, P. L. Huang, J. Ma et al., “Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine,” Journal of Cerebral Blood Flow and Metabolism, vol. 16, no. 5, pp. 981–987, 1996.
  124. V. L. Dawson, V. M. Kizushi, P. L. Huang, S. H. Snyder, and T. M. Dawson, “Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice,” Journal of Neuroscience, vol. 16, no. 8, pp. 2479–2487, 1996. View at Scopus
  125. S. C. Keswani, M. Bosch-Marcé, N. Reed, A. Fischer, G. L. Semenza, and A. Höke, “Nitric oxide prevents axonal degeneration by inducing HIF-1-dependent expression of erythropoietin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 4986–4990, 2011. View at Publisher · View at Google Scholar · View at PubMed
  126. A. Xenocostas, W. K. Cheung, F. Farrell et al., “The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin,” European Journal of Clinical Pharmacology, vol. 61, no. 3, pp. 189–195, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  127. M. Sakanaka, T. C. Wen, S. Matsuda et al., “In vivo evidence that erythropoietin protects neurons from ischemic damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 8, pp. 4635–4640, 1998. View at Publisher · View at Google Scholar · View at Scopus
  128. Y. Sadamoto, K. Igase, M. Sakanaka et al., “Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery,” Biochemical and Biophysical Research Communications, vol. 253, no. 1, pp. 26–32, 1998. View at Publisher · View at Google Scholar · View at PubMed
  129. M. Bernaudin, A.-S. Nedelec, D. Divoux, E. T. MacKenzie, E. Petit, and P. Schumann-Bard, “Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 4, pp. 393–403, 2002.
  130. Y. Xiong, M. Chopp, and C. P. Lee, “Erythropoietin improves brain mitochondrial function in rats after traumatic brain injury,” Neurological Research, vol. 31, no. 5, pp. 496–502, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. Y. Zhang, Y. Xiong, A. Mahmood et al., “Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit,” Brain Research, vol. 1294, pp. 153–164, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  132. E. Taoufik, E. Petit, D. Divoux et al., “TNF receptor I sensitizes neurons to erythropoietin-and VEGF-mediated neuroprotection after ischemic and excitotoxic injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 16, pp. 6185–6190, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. M. Yamada, C. Burke, P. Colditz, D. W. Johnson, and G. C. Gobe, “Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain,” Journal of Pathology, vol. 224, no. 1, pp. 101–109, 2011. View at Publisher · View at Google Scholar · View at PubMed
  134. E. Gunnarson, Y. Song, J. M. Kowalewski et al., “Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1602–1607, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  135. K. Krügel, A. Wurm, R. Linnertz et al., “Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase- and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor,” Neuroscience, vol. 165, no. 4, pp. 1147–1158, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. K. Prass, A. Scharff, K. Ruscher et al., “Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin,” Stroke, vol. 34, no. 8, pp. 1981–1986, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  137. S. Malhotra, S. I. Savitz, L. Ocava, and D. M. Rosenbaum, “Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack,” Journal of Neuroscience Research, vol. 83, no. 1, pp. 19–27, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  138. M. H. Theus, L. Wei, L. Cui et al., “In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain,” Experimental Neurology, vol. 210, no. 2, pp. 656–670, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. K. Zaman, H. Ryu, D. Hall et al., “Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin,” Journal of Neuroscience, vol. 19, no. 22, pp. 9821–9830, 1999. View at Scopus
  140. A. Siddiq, I. A. Ayoub, J. C. Chavez et al., “Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: a target for neuroprotection in the central nervous system,” Journal of Biological Chemistry, vol. 280, no. 50, pp. 41732–41743, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. J. Liu, P. Narasimhan, F. Yu, and P. H. Chan, “Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin,” Stroke, vol. 36, no. 6, pp. 1264–1269, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. J. Milosevic, M. Maisel, F. Wegner et al., “Lack of hypoxia-inducible factor-1α impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling,” Journal of Neuroscience, vol. 27, no. 2, pp. 412–421, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. C. Leconte, E. Tixier, T. Freret et al., “Delayed hypoxic postconditioning protects against cerebral ischemia in the mouse,” Stroke, vol. 40, no. 10, pp. 3349–3355, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. A. Aydin, K. Genç, M. Akhisaroglu, K. Yorukoglu, N. Gokmen, and E. Gonullu, “Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury,” Brain and Development, vol. 25, no. 7, pp. 494–498, 2003. View at Publisher · View at Google Scholar · View at Scopus
  145. H. Matsushita, M. V. Johnston, M. S. Lange, and M. A. Wilson, “Protective effect of erythropoietin in neonatal hypoxic ischemia in mice,” NeuroReport, vol. 14, no. 13, pp. 1757–1761, 2003. View at Publisher · View at Google Scholar · View at Scopus
  146. T. C. Wen, M. Rogido, H. Peng, T. Genetta, J. Moore, and A. Sola, “Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats,” Neuroscience, vol. 139, no. 3, pp. 803–811, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. A. Kumral, N. Uysal, K. Tugyan et al., “Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats,” Behavioural Brain Research, vol. 153, no. 1, pp. 77–86, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. E. Spandou, V. Soubasi, S. Papoutsopoulou et al., “Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia,” Neuroscience Letters, vol. 366, no. 1, pp. 24–28, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  149. Y. Sun, C. Zhou, P. Polk, A. Nanda, and J. H. Zhang, “Mechanisms of Erythropoietin-induced Brain Protection in Neonatal Hypoxia-Ischemia Rat Model,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 2, pp. 259–270, 2004.
  150. E. J. Demers, R. J. McPherson, and S. E. Juul, “Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia,” Pediatric Research, vol. 58, no. 2, pp. 297–301, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. F. F. Gonzalez, P. McQuillen, D. Mu et al., “Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke,” Developmental Neuroscience, vol. 29, no. 4-5, pp. 321–330, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  152. E. Spandou, Z. Papadopoulou, V. Soubasi et al., “Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats,” Brain Research, vol. 1045, no. 1-2, pp. 22–30, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. M. M. McClure, S. W. Threlkeld, and R. H. Fitch, “Auditory processing and learning/memory following erythropoietin administration in neonatally hypoxic-ischemic injured rats,” Brain Research, vol. 1132, no. 1, pp. 203–209, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  154. E. Spandou, S. Papoutsopoulou, V. Soubasi et al., “Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain,” Brain Research, vol. 1021, no. 2, pp. 167–172, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  155. T. C. Wen, M. Rogido, T. Genetta, and A. Sola, “Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain,” Neuroscience Letters, vol. 355, no. 3, pp. 165–168, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. U. Yiş, S. H. Kurul, A. Kumral et al., “Effect of erythropoietin on oxygen-induced brain injury in the newborn rat,” Neuroscience Letters, vol. 448, no. 3, pp. 245–249, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  157. A. M. Kaindl, M. Sifringer, A. Koppelstaetter et al., “Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes,” Annals of Neurology, vol. 64, no. 5, pp. 523–534, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  158. S. E. Juul, R. P. Beyer, T. K. Bammler, R. J. Mcpherson, J. Wilkerson, and F. M. Farin, “Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus,” Pediatric Research, vol. 65, no. 5, pp. 485–492, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  159. S. E. Juul, R. J. McPherson, T. K. Bammler, J. Wilkerson, R. P. Beyer, and F. M. Farin, “Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model,” Developmental Neuroscience, vol. 30, no. 4, pp. 231–242, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. A. Kumral, H. Baskin, D. C. Yesilirmak et al., “Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain,” Neonatology, vol. 92, no. 4, pp. 269–278, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  161. Y. Shen, H. M. Yu, T. M. Yuan, W. Z. Gu, and Y. D. Wu, “Erythropoietin attenuates white matter damage, proinflammatory cytokine and chemokine induction in developing rat brain after intra-uterine infection,” Neuropathology, vol. 29, no. 5, pp. 528–535, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  162. B. A. Kellert, R. J. McPherson, and S. E. Juul, “A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats,” Pediatric Research, vol. 61, no. 4, pp. 451–455, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  163. M. Mazur, R. H. Miller, and S. Robinson, “Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury: laboratory investigation,” Journal of Neurosurgery: Pediatrics, vol. 6, no. 3, pp. 206–221, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  164. Y. Xiong, D. Lu, C Qu et al., “Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice,” Journal of Neurosurgery, vol. 109, no. 3, pp. 510–521, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  165. M. Iwai, R. A. Stetler, J. Xing et al., “Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury,” Stroke, vol. 41, no. 5, pp. 1032–1037, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  166. S. E. Juul, R. J. McPherson, L. A. Bauer, K. J. Ledbetter, C. A. Gleason, and D. E. Mayock, “A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety,” Pediatrics, vol. 122, no. 2, pp. 383–391, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  167. J. C. Fauchère, C. Dame, R. Vonthein et al., “An approach to using recombinant erythropoietin for neuroprotection in very preterm infants,” Pediatrics, vol. 122, no. 2, pp. 375–382, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  168. P. Villa, P. Bigini, T. Mennini et al., “Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis,” Journal of Experimental Medicine, vol. 198, no. 6, pp. 971–975, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  169. U. Dirnagl, C. Iadecola, and M. A. Moskowitz, “Pathobiology of ischaemic stroke: an integrated view,” Trends in Neurosciences, vol. 22, no. 9, pp. 391–397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  170. V. Witko-Sarsat, P. Rieu, B. Descamps-Latscha, P. Lesavre, and L. Halbwachs-Mecarelli, “Neutrophils: molecules, functions and pathophysiological aspects,” Laboratory Investigation, vol. 80, no. 5, pp. 617–654, 2000. View at Scopus
  171. J. Zhang, Y. Li, Y. Cui et al., “Erythropoietin treatment improves neurological functional recovery in EAE mice,” Brain Research, vol. 1034, no. 1-2, pp. 34–39, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  172. C. Savino, R. Pedotti, F. Baggi et al., “Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 172, no. 1-2, pp. 27–37, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  173. D. Agnello, P. Bigini, P. Villa et al., “Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis,” Brain Research, vol. 952, no. 1, pp. 128–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  174. R. Yuan, Y. Maeda, W. Li, W. Lu, S. Cook, and P. Dowling, “Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE,” PLoS One, vol. 3, no. 4, Article ID e1924, 2008. View at Publisher · View at Google Scholar · View at PubMed
  175. M. B. Sättler, D. Merkler, K. Maier et al., “Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis,” Cell Death and Differentiation, vol. 11, supplement 2, pp. S181–S192, 2004. View at Publisher · View at Google Scholar · View at PubMed
  176. K. Genc, S. Genc, H. Baskin, and I. Semin, “Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes,” Physiological Research, vol. 55, no. 1, pp. 33–38, 2006. View at Scopus
  177. S. Patel, M. J. Rowe, S. A. Winters, and R. K. Ohls, “Elevated erythropoietin mRNA and protein concentrations in the developing human eye,” Pediatric Research, vol. 63, no. 4, pp. 394–397, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  178. D. Watanabe, K. Suzuma, S. Matsui et al., “Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy,” New England Journal of Medicine, vol. 353, no. 8, pp. 782–792, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  179. Z. Tong, Z. Yang, S. Patel et al., “Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 19, pp. 6998–7003, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  180. N. Scheerer, N. Dünker, S. Imagawa, M. Yamamoto, N. Suzuki, and J. Fandrey, “The anemia of the newborn induces erythropoietin expression in the developing mouse retina,” American Journal of Physiology, vol. 299, no. 1, pp. R111–R118, 2010. View at Publisher · View at Google Scholar · View at PubMed
  181. C. Grimm, A. Wenzel, D. Stanescu et al., “Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration,” Journal of Neuroscience, vol. 24, no. 25, pp. 5651–5658, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  182. J. Chen, K. M. Connor, C. M. Aderman, and L. E. H. Smith, “Erythropoietin deficiency decreases vascular stability in mice,” Journal of Clinical Investigation, vol. 118, no. 2, pp. 526–533, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  183. H. Ehrenreich, M. Hasselblatt, C. Dembowski et al., “Erythropoietin therapy for acute stroke is both safe and beneficial,” Molecular Medicine, vol. 8, no. 8, pp. 495–505, 2002. View at Scopus
  184. H. Ehrenreich, K. Weissenborn, H. Prange et al., “Recombinant human erythropoietin in the treatment of acute ischemic stroke,” Stroke, vol. 40, no. 12, pp. e647–e656, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  185. L. Jia, M. Chopp, L. Zhang, M. Lu, and Z. Zhang, “Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke,” Stroke, vol. 41, no. 9, pp. 2071–2076, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  186. A. Zechariah, A. Elali, and D. M. Hermann, “Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice,” Stroke, vol. 41, no. 5, pp. 1008–1012, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  187. Y. Meng, Y. Xiong, A. Mahmood, Y. Zhang, Q. Changsheng, and M. Chopp, “Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats: laboratory investigation,” Journal of Neurosurgery, vol. 115, no. 3, pp. 550–560, 2011. View at Publisher · View at Google Scholar · View at PubMed
  188. M. A. Pfeffer, E. A. Burdmann, C. Y. Chen et al., “A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease,” New England Journal of Medicine, vol. 361, no. 21, pp. 2019–2032, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  189. A. K. Singh, L. Szczech, K. L. Tang et al., “Correction of anemia with epoetin alfa in chronic kidney disease,” New England Journal of Medicine, vol. 355, no. 20, pp. 2085–2098, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  190. A. Besarab, W. K. Bolton, J. K. Browne et al., “The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin,” New England Journal of Medicine, vol. 339, no. 9, pp. 584–590, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  191. S. D. Solomon, H. Uno, E. F. Lewis et al., “Erythropoietic response and outcomes in kidney disease and type 2 diabetes,” New England Journal of Medicine, vol. 363, no. 12, pp. 1146–1155, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  192. B. Leyland-Jones, “Breast cancer trial with erythropoietin terminated unexpectedly,” Lancet Oncology, vol. 4, no. 8, pp. 459–460, 2003. View at Publisher · View at Google Scholar · View at Scopus
  193. M. Henke, R. Laszig, C. Rübe et al., “Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial,” Lancet, vol. 362, no. 9392, pp. 1255–1260, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  194. C. L. Bennett, S. M. Silver, B. Djulbegovic et al., “Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia,” Journal of the American Medical Association, vol. 299, no. 8, pp. 914–924, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  195. S. Erbayraktar, G. Grasso, A. Sfacteria et al., “Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 11, pp. 6741–6746, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  196. H.-K. Yip, T.-H. Tsai, H.-S. Lin et al., “Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke,” Critical Care, vol. 15, no. 1, article R40, 2011. View at Publisher · View at Google Scholar · View at PubMed
  197. S. C. Cramer, C. Fitzpatrick, M. Warren et al., “The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial,” Stroke, vol. 41, no. 5, pp. 927–931, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  198. T. Wüstenberg, M. Begemann, C. Bartels et al., “Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia,” Molecular Psychiatry, vol. 16, no. 1, pp. 26–36, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  199. M. Leis, P. Gliezzi, G. Grasso et al., “Derivatives of erythropoietin that are tissue protective but not erythropoietic,” Science, vol. 305, no. 5681, pp. 239–242, 2004. View at Publisher · View at Google Scholar · View at PubMed
  200. R. Teng, O. Gavrilova, N. Suzuki, et al., “Disrupted erythropoeitin signaling promotes obesity and alters hypothalamus proopiomelanocortin production,” Nature Communications, vol. 2, article 520, 2011.
  201. A. Foskett, M. Alnaeeli, L. Wang, R. Teng, and C. T. Noguchi, “The effects of erythropoietin dose titration during high-fat diet-induced obesity,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 373781, 8 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  202. O. Katz, M. Stuible, N. Golishevski et al., “Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models,” Journal of Endocrinology, vol. 205, no. 1, pp. 87–95, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  203. P. Hojman, C. Brolin, H. Gissel et al., “Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles,” PLoS One, vol. 4, no. 6, Article ID e5894, 2009. View at Publisher · View at Google Scholar · View at PubMed
  204. D. Choi, S. A. Schroer, S. Y. Lu et al., “Erythropoietin protects against diabetes through direct effects on pancreatic β cells,” Journal of Experimental Medicine, vol. 207, no. 13, pp. 2831–2842, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus